Authors



Frederick J. Bloom Jr, MD, MMM

Latest:

Unintended Consequences of a Quality Measure for Acute Bronchitis

A quality measure reduced antibiotic use for patients with acute bronchitis but led to use of an alternative diagnosis, offsetting most of the observed improvement.





Jeanne Madden, PhD

Latest:

Effect of High-Deductible Insurance on Health Care Use in Bipolar Disorder

High-deductible health plan members with bipolar disorder experienced a reduction in nonpsychiatrist mental health provider visits but no changes in other utilization.





Ashish Malhotra, MD, MS

Latest:

Elderly Veterans With Dual Eligibility for VA and Medicare Services: Where Do They Obtain a Colonoscopy?

This study examines factors impacting the receipt of an outpatient colonoscopy by VA or non-VA providers in older veterans dually eligible for VA/Medicare benefits.










Stephen J. Kogut, PhD

Latest:

The Incidence and Costs of Hypoglycemia in Type 2 Diabetes

The overall incidence of hypoglycemia was considerable in this large working-age population and was associated with $52 million (2008 dollars) in direct medical costs.


Alexandra Halalau, MD

Latest:

Impact of a Pharmacist-Managed Diabetes Clinic on Quality Measures

This study evaluated a pharmacist-managed diabetes clinic to determine its impact on diabetes-related quality measures.(For Tables and Figures, please access the PDF on last page.)


Bethany Sawchyn, PharmD

Latest:

Perspective: FDA/CMS Parallel Review Advances Coverage for Cancer Comprehensive Genomic Profiling

Authors from Foundation Medicine explain the regulatory path that led to approval of FoundationOne CDx.


Sarah K. Emond, MPP

Latest:

ICER's Value Assessment Framework: Capturing the Patient Experience

The Institute for Clinical and Economic Review (ICER), has established a robust health technology assessment strategy for engaging patients so that the entire process is informed by the patient experience and what “value” means to them.



Amy Tenderich, MA

Latest:

Community as Part of the Prescription: Social Media in Diabetes Care

This commentary was adapted from an appearance by the authors at Patient-Centered Diabetes Care, a conference jointly presented by The American Journal of Managed Care and Joslin Diabetes Center.


Jon B. Christianson, PhD

Latest:

Do Health Systems Respond to the Quality of Their Competitors?

The authors determined whether Minnesota health systems responded to competitors’ publicly reported performance. Low performers fell further behind high performers, suggesting that reporting was not associated with quality competition.


Jeph Herrin, PhD

Latest:

Changing Trends in Type 2 Diabetes Mellitus Treatment Intensification, 2002-2010

Glycemic control can lower the risk of diabetes-related complications, and delayed treatment intensification can impede optimal diabetes care.This study examines trends in hyperglycemia treatment intensification between 2002 and 2010.


Matthew J. Gurka, PhD

Latest:

Geographic Access to Endocrinologists for Florida's Publicly Insured Children With Diabetes

Enrollment, claims, and spatial data are used to demonstrate the importance of outreach strategies for families in rural areas who have children with diabetes. Spatial barriers, alone, do not fully elucidate racial/ethnic disparities in pediatric diabetes for street-level location. (For Tables and the Figure, please access the PDF on the last page.)


Terri Castle, RN, MS

Latest:

Antidepressant Medication Adherence via Interactive Voice Response Telephone Calls

Our age-adjusted evaluation found that IVR calls had little impact on antidepressant medication adherence rates and that rates generally increased markedly with increasing age.


Marzieh Vali, MS, BS

Latest:

Guideline Concordance of New Statin Prescriptions: Who Got a Statin?

New statin prescriptions at the Veterans Health Administration were reviewed using a cross-sectional study design. Statins were frequently prescribed outside of guideline recommendations.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo